Identification of nine key genes by bioinformatics analysis for predicting poor prognosis in smoking-induced lung adenocarcinoma.
GSE31210
bioinformatics analysis
core genes
lung adenocarcinoma
smoking
Journal
Lung cancer management
ISSN: 1758-1974
Titre abrégé: Lung Cancer Manag
Pays: England
ID NLM: 101588392
Informations de publication
Date de publication:
27 Apr 2020
27 Apr 2020
Historique:
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
30
4
2020
Statut:
epublish
Résumé
To screen and identify key genes related to the development of smoking-induced lung adenocarcinoma (LUAD). We obtained data from the GEO chip dataset GSE31210. The differentially expressed genes were screened by GEO2R. The protein interaction network of differentially expressed genes was constructed by STRING and Cytoscape. Finally, core genes were screened. The overall survival time of patients with the core genes was analyzed by Kaplan-Meier method. Gene ontology and Kyoto encyclopedia of genes and genomes bioaccumulation was calculated by DAVID. Functional enrichment analysis indicated that nine key genes were actively involved in the biological process of smoking-related LUAD. 23 core genes and nine key genes among them were correlated with adverse prognosis of LUAD induced by smoking.
Identifiants
pubmed: 32346404
doi: 10.2217/lmt-2020-0009
pmc: PMC7186853
doi:
Types de publication
Journal Article
Langues
eng
Pagination
LMT30Informations de copyright
© 2020 Chuanli Ren.
Déclaration de conflit d'intérêts
Financial & competing interests disclosure This study was supported by the National Nature Science Foundation of China (81573220), the Foundation for Young Medical Scholar in Jiangsu Province (QNRC2016325; QNRC2016333) and Foundation for Young Medical Scholars in Yangzhou (RCC201835). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. We thank C Kerr from Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
Références
Tohoku J Exp Med. 2011;225(2):95-101
pubmed: 21908955
Cell. 2012 Sep 14;150(6):1121-34
pubmed: 22980976
Carcinogenesis. 2019 Oct 16;40(10):1240-1250
pubmed: 30915466
Mol Cancer Res. 2014 Jan;12(1):14-23
pubmed: 24398389
Breast Cancer Res Treat. 2016 Oct;159(3):499-511
pubmed: 27592112
Cell Oncol. 2008;30(5):389-95
pubmed: 18791270
Cell Mol Life Sci. 2011 Mar;68(5):893-901
pubmed: 20734103
Pathol Res Pract. 2017 Aug;213(8):964-968
pubmed: 28559119
Carcinogenesis. 2017 Oct 26;38(11):1112-1118
pubmed: 28968711
Int J Med Sci. 2018 Nov 5;15(14):1676-1685
pubmed: 30588191
J Surg Oncol. 2018 Dec;118(7):1115-1121
pubmed: 30261114
J Exp Clin Cancer Res. 2017 Aug 7;36(1):105
pubmed: 28784180
Oncogene. 2002 Oct 21;21(48):7365-75
pubmed: 12379879
Oncol Lett. 2018 Sep;16(3):3373-3379
pubmed: 30127937
J Cell Physiol. 2019 Dec;234(12):22742-22752
pubmed: 31127628
PLoS Med. 2016 Dec 6;13(12):e1002162
pubmed: 27923066
Oncogene. 2003 Nov 24;22(53):8581-9
pubmed: 14634620
Nature. 1998 Mar 19;392(6673):300-3
pubmed: 9521327
Hepatology. 2011 Apr;53(4):1226-36
pubmed: 21480327
Dis Markers. 2019 Apr 9;2019:5451290
pubmed: 31093306
Cell. 2013 Feb 14;152(4):768-77
pubmed: 23415226
Biochem Biophys Res Commun. 2009 Apr 17;381(4):554-9
pubmed: 19233139
Nature. 1996 Jan 11;379(6561):180-2
pubmed: 8538771
Cancer Lett. 2007 Sep 18;255(1):57-70
pubmed: 17493746
Biosci Rep. 2019 Feb 26;39(2):
pubmed: 30765611
Cell. 2012 Sep 14;150(6):1107-20
pubmed: 22980975
Cell Cycle. 2008 Feb 1;7(3):365-72
pubmed: 18235244
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3378-3385
pubmed: 29917189
Transl Lung Cancer Res. 2016 Jun;5(3):288-300
pubmed: 27413711